70.23  1.139 (1.65%)		09-26 16:00
Open: 69.935 High: 70.325 Volume: 11,949		Pre. Close: 69.091 Low: 69.68 Market Cap: 589(M)

Short term
Mid term
Targets	6-month :	82.62	1-year :	83.88
Resists	First :	70.74	Second :	71.81
Pivot price	70.57
Supports	First :	68.99	Second :	57.4
MAs	MA(5) :	70.04	MA(20) :	70.75
	MA(100) :	67.5	MA(250) :	68.08
MACD	MACD :	0.1	Signal :	0.3
%K %D	K(14,3) :	23.7	D(3) :	23.8
RSI	RSI(14): 50.5
52-week	High :	73.27	Low :	58.97

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IHE ] has closed above bottom band by 36.8%. Bollinger Bands are 34% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	70.43 - 70.82	70.82 - 71.18
Low:	68.62 - 69.14	69.14 - 69.63
Close:	69.47 - 70.23	70.23 - 70.92

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Fri, 26 Sep 2025
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Zacks Investment Research

Tue, 16 Sep 2025
iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.3124 - MSN

Tue, 02 Sep 2025
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance

Tue, 12 Aug 2025
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network

Fri, 08 Aug 2025
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail

Thu, 07 Aug 2025
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.